Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Berchuck

Showing results (11-20 of 191) with videos related to

Pageof 20
Sort By:
American Journal of Perinatology|April 1, 1984
Cervicovaginal fistula formation: a new complication of Shirodkar cerclageA Berchuck, R J Sokol
Obstetrical & Gynecological Survey|September 11, 1990
The role of tumor markers in gynecologic oncologyG Olt, A Berchuck, R C Bast
Journal of the National Cancer Institute|July 2, 1997
Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancerJ M Schildkraut, E Bastos, A Berchuck
Journal of the National Cancer Institute|April 25, 1992
Malignant transformation of ovarian epitheliumR C Bast, I Jacobs, A Berchuck
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|July 1, 1989
Pneumoperitoneum due to peritoneovaginal fistula following hysterectomyL S Massad, K Santoriello, A Berchuck
Obstetrics and Gynecology|February 1, 1996
An inevitable dilemma: prenatal testing for mutations in the BRCA1 breast-ovarian cancer susceptibility geneJ M Lancaster, R W Wiseman, A Berchuck
Seminars in Surgical Oncology|January 1, 1990
Gynecologic tumor markersG J Olt, A Berchuck, R C Bast
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 17, 1999
Genetic susceptibility testing and prophylactic oophorectomyA Berchuck, M E Carney, P A Futreal
Current Opinion in Oncology|October 11, 1992
Biology and therapy with biologic agents in gynecologic cancerJ R Wiener, A Berchuck, R C Bast
Progress in Clinical and Biological Research|January 1, 1996
Molecular genetic features of ovarian cancerA Berchuck, M F Kohler, R C Bast
Pageof 20

Showing results (11-20 of 191) with videos related to

Sort By:
Pageof 20
American Journal of Perinatology|April 1, 1984
Cervicovaginal fistula formation: a new complication of Shirodkar cerclageA Berchuck, R J Sokol
Obstetrical & Gynecological Survey|September 11, 1990
The role of tumor markers in gynecologic oncologyG Olt, A Berchuck, R C Bast
Journal of the National Cancer Institute|July 2, 1997
Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancerJ M Schildkraut, E Bastos, A Berchuck
Journal of the National Cancer Institute|April 25, 1992
Malignant transformation of ovarian epitheliumR C Bast, I Jacobs, A Berchuck
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|July 1, 1989
Pneumoperitoneum due to peritoneovaginal fistula following hysterectomyL S Massad, K Santoriello, A Berchuck
Obstetrics and Gynecology|February 1, 1996
An inevitable dilemma: prenatal testing for mutations in the BRCA1 breast-ovarian cancer susceptibility geneJ M Lancaster, R W Wiseman, A Berchuck
Seminars in Surgical Oncology|January 1, 1990
Gynecologic tumor markersG J Olt, A Berchuck, R C Bast
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 17, 1999
Genetic susceptibility testing and prophylactic oophorectomyA Berchuck, M E Carney, P A Futreal
Current Opinion in Oncology|October 11, 1992
Biology and therapy with biologic agents in gynecologic cancerJ R Wiener, A Berchuck, R C Bast
Progress in Clinical and Biological Research|January 1, 1996
Molecular genetic features of ovarian cancerA Berchuck, M F Kohler, R C Bast
Pageof 20